Search This Blog

Wednesday, April 8, 2020

Dow Jumps Nearly 800 Points After Sanders Drops Out


The stock market rallied on Wednesday after Senator Bernie Sanders (D-Vt.) dropped out of the presidential race—removing a key source of political unpredictability for Wall Street amid the ongoing economic uncertainty caused by the coronavirus pandemic.
  • The Dow Jones industrial average was up 3.4%, almost 800 points, on Wednesday, while the S&P 500 rose 3.4% and the Nasdaq Composite gained 2.6%.
  • Giving stocks an extra boost was Sanders’ announcement that he would be dropping out of the 2020 presidential race, since some of his progressive policy proposals, including Medicare-for-All, had sparked concern among business leaders on Wall Street.
  • The market rally gained steam throughout the day, as investors also continue to focus on progress being made to contain the coronavirus pandemic and when the economy can eventually get back on track.
  • Wall Street has cheered news that the number of new COVID-19 cases, both in the U.S. and globally, has started to slow since last Friday, according to data from Johns Hopkins University.
  • Dr. Anthony Fauci, the White House’s top expert on infectious diseases, told Fox News on Wednesday that the number of deaths in the U.S. is lower than originally projected, saying that there should be a turnaround after this week.
Crucial statistic: The S&P 500 is now up more than 20% from its coronavirus sell-off low point in late March. Markets have steadily rebounded in recent weeks, taking solace in fiscal stimulus packages from the federal government and more recently, signs that coronavirus containment efforts are paying off.
Crucial quote: “The difference between now and the start of the pandemic is that we can at least see the end,” says Brad McMillan, chief investment officer for Commonwealth Financial Network. Stocks have subsequently gotten a boost, as investors are increasingly focusing on when the economy can recover: “We can see that we have flattened the curve.”
Big number: 25% of Americans have either lost their job or seen their wages slashed as a result of the coronavirus shutdown, according to CNBC’s All-America Economic Survey. The survey, which gauges the public’s view of the U.S. economy, posted the biggest and fastest decline in sentiment ever. On the flip side, however, some 51% of respondents said the economy will improve in 2021.
Key background: Stocks closed slightly negative on Tuesday, after a volatile session in which the major indexes pared back almost 4% of earlier gains. That followed a massive market rally on Monday, in which the Dow posted its third-biggest point gain ever. The Dow gained 7.8%, more than 1,600 points on Monday, while the S&P 500 jumped 7.2% and the Nasdaq rose 7.3%.
https://www.forbes.com/sites/sergeiklebnikov/2020/04/08/dow-jumps-nearly-800-points-after-sanders-drops-out-of-presidential-race/#68a892c34fc1

U.S. to seize exports of masks and gloves amid coronavirus crisis

The United States will seize exports of key protective medical gear until it determines whether the equipment should be kept in the country to combat the spread of the new coronavirus, two federal agencies announced on Wednesday.
U.S. Customs and Border Protection (CBP) will hold exports of respirators, surgical masks and surgical gloves, according to a joint announcement made with the Federal Emergency Management Agency. FEMA will then determine if the equipment should be returned for use in the United States, purchased by the U.S. government or exported.
President Donald Trump issued a memorandum on Friday that directed federal agencies to use any authority necessary to keep the highly sought-after medical supplies in the United States.
Governors, mayors and physicians have voiced alarm for weeks over crippling scarcities of personal protective gear for first-responders and front-line healthcare workers, as well as ventilators and other medical supplies.
The move to seize exports will include N95 respirator masks, which filter airborne particles and are used to protect against COVID-19, the potentially lethal respiratory disease caused by the new coronavirus.
The U.S. manufacturing company 3M Co, a leading producer of the masks worldwide, said on Monday that it had reached a deal with the Trump administration that would allow it to continue to export the masks to Canada and Latin America despite the new restrictions. The company had said days earlier that ceasing exports to those regions would have “humanitarian implications.”
A federal regulation that outlines FEMA’s procedures for seizing and vetting the exports will go into effect on Friday and remain in place until Aug. 10, according to a draft version posted online.
FEMA will aim to make decisions about exports quickly and seek to minimize disruptions to the supply chain, the draft regulation said.

Some state and local government officials have accused FEMA in recent days of confiscating shipments of masks and other supplies coming from overseas.
An official with the U.S. Department of Homeland Security who requested anonymity to discuss the matter earlier this week said half of the protective gear brought to the United States on U.S. government flights can be redirected to high-need areas around the country, but disputed the idea that the equipment had been seized.
https://www.reuters.com/article/us-health-coronavirus-usa-supplies/u-s-to-seize-exports-of-masks-and-gloves-amid-coronavirus-crisis-idUSKCN21Q30Q

NY hospital sends ‘borderline’ Covid-19 patients home with oxygen monitors

Some coronavirus patients who would have been admitted into the emergency department at a New York hospital are being sent home with an oxygen-monitoring device as the city’s medical system struggles to reserve resources for only the sickest people.
The new program at NewYork-Presbyterian Hospital is an example of how doctors are adapting and loosening normal protocols to ease the strain on emergency rooms and intensive care units in New York state, the epicenter of the coronavirus pandemic in the United States.
Since last week, more than 200 people with confirmed or suspected COVID-19, the respiratory illness caused by the virus, have been sent home with a pulse oximeter to track their oxygen levels. A doctor or nurse practitioner follows up with them via video conference.
“Some of these patients might have been on the borderline of admission,” Dr. Rahul Sharma, who is overseeing the program as the chief of emergency medicine at Presbyterian’s Weill Cornell Medical Center, said in an interview.
An oximeter is a small electronic device that clips onto a fingertip to indirectly measure the oxygen saturation of a patient’s blood. In severe COVID-19 cases, the virus can block up the lungs, hindering their ability to pass oxygen from the air into the bloodstream. While most who contract the virus recover, it has killed at least 4,900 people in the city, according to a Reuters tally.

Some of the NewYork-Presbyterian patients are also being sent home with a 30lb (14 kg) portable oxygen concentrating machine which sends oxygen-rich air through a nasal cannula, a two-pronged tube inserted into the nostrils.
The patient is asked to log their oximeter readings to share with a doctor or nurse practitioner at 12-hour and 24-hour consultations. The patient may be re-admitted to the hospital if they take a turn for the worse.
No patient in the program is known to have died at home as of Wednesday, but about 15 percent were asked to return to hospital to be admitted for inpatient care, a hospital spokeswoman said.
At least two other hospital systems outside of New York unveiled similar new programs using oximeters in late March. Doctors at other hospitals said Presbyterian’s approach could have benefits for patients with a disease about which they still have much to learn.

“There’s no guarantees in either direction, there are risks to hospitalization and there are risks with sending people home,” Dr. Laura Burke, an assistant professor of emergency medicine at Harvard Medical School, said in an interview.
Doctors have noticed there can be a worrisome lag in symptoms among some COVID-19 patients, with oxygen saturation dropping for some time before a patient is aware of breathing problems.
For patients that turn up at an emergency department with other COVID-19 symptoms, giving a pulse oximeter to use at home could be one way to “err on the side of safety,” Burke said.
https://www.reuters.com/article/us-health-coronavirus-usa-home/new-york-hospital-sends-some-borderline-covid-19-patients-home-with-oxygen-monitors-idUSKCN21Q3F0

FDA OKs Pfizer’s Braftovi combo for certain type of colorectal cancer

The FDA approves the combination of Pfizer’s (NYSE:PFE) Braftovi (encorafenib) and Eli Lilly’s (NYSE:LLY) Erbitux (cetuximab) for the treatment of adults with BRAF V600E mutation-positive metastatic colorectal cancer who have received prior therapy, a Priority Review and Breakthrough Therapy indication.
A pivotal late-stage showed that the combo extended overall survival compared to cetuximab + chemo.
https://seekingalpha.com/news/3559539-fda-oks-pfizers-braftovi-combo-for-certain-type-of-colorectal-cancer

The top 2 meds prescribed for COVID-19 patients

Azithromycin and hydroxychloroquine are the top two prescription medications physicians around the world have used to treat COVID-19 patients, according to a new global survey.
Sermo, a healthcare data collection company and social platform for physicians, is conducting a weekly survey among physicians globally. The current results are for the second wave of the survey, conducted March 30-April 2. Physicians could select more than one option.
Of the 1,662 physicians who reported treating COVID-19 patients, half said they used azithromycin or similar antibiotics; 44 percent said they used hydroxychloroquine or chloroquine; and 36 percent said they used bronchodilators.
The physicians who reported treating COVID-19 patients also said that certain over-the-counter medications have been effective, including acetaminophen (42 percent) and cold medications, such antihistamines, decongestants and cough medications (29 percent).
https://www.beckershospitalreview.com/patient-safety-outcomes/the-top-2-meds-prescribed-for-covid-19-patients.html

Medtronic sees 5x ramp in ventilator production to meet COVID-19 demand

Medtronic (NYSE:MDT) announces that its Puritan Bennett 560 ventilator will be available next month in the U.S. under emergency use authorization from the FDA (it is currently sold in 35 countries around the world at an average price of just under $10K).
By month-end, it expects to be producing 400 ventilators per week (four models), increasing to 700/week by the end of May and 1,000/week by the end of June, a five-fold increase compared to pre-COVID-19 levels. It projects that it will produce 25K ventilators across all platforms over the next six months.
A remote access feature for another ventilator model, the PB980, enabling clinicians to adjust the settings outside of the ICU, is in limited market release in the U.S. in two hospitals. If the feature is well-received, the release will be expanded later this month.
Shares up 1% after hours.
https://seekingalpha.com/news/3559507-medtronic-sees-5x-ramp-in-ventilator-production-to-meet-covidminus-19-demand

Facebook building coronavirus ‘heat map’ by asking users about symptoms

Facebook announced it would start to ask some of its U.S.-based users about their health in an effort to give researchers more information about self-reported COVID-19 patients.
In a blog post, the Mark Zuckerberg-led company said it will put a link at the top of some users’ News Feeds to point them to the survey that could help pinpoint where health care resources are best needed.
“The survey — run by Carnegie Mellon University Delphi Research Center — will be used to generate new insights on how to respond to the crisis, including heat maps of self-reported symptoms,” Facebook wrote in the blog post. “This information can help health systems plan where resources are needed and potentially when, where and how to reopen parts of society. If the results are helpful, we’ll make similar surveys available in other parts of the world.”
There will be three new tools as part of the project: a co-location map that could help predict where COVID-19 cases may appear next; movement range tools that show where people are staying near home or traveling around town; and a “social connectedness index,” which aims to show friendships across states and countries, to help epidemiologists better predict where the disease will spread and what areas might need support.
The data, which is part of Facebook’s Data for Good project, would be aggregated.
“Individual survey responses with Facebook, and Facebook won’t share information about who you are with the researchers,” Facebook added in the post.
To protect privacy, a random ID number will be sent to Carnegie Mellon that will get sent back to Facebook once a user completes the survey. A single data point, known as a “weight value,” will help to correct for sample bias.
“COVID-19 has inherent delays that challenge the pace at which we seek to evaluate policy impact towards a measured response,” Dr. Daniel Klein of the Institute for Disease Modeling said in the post. “Mobility data from Facebook’s Data for Good program provides a near real-time view of important correlates of disease transmission. This data, in combination with other sources, allows us to make better models to inform public health decisions.”
Facebook added that if the results are helpful to researchers, similar surveys would come for other parts of the globe.
The move is the latest from the tech giant in the fight against the coronavirus pandemic. In March, Facebook provided information for its more than 2 billion users on how to spot fake news in an effort to stop the spread of misinformation.
Separately in March, Facebook said it would provide $100 million in grants to aid small businesses during the pandemic.
As of Tuesday morning, more than 1.36 million coronavirus cases have been diagnosed worldwide, more than 368,000 of which are in the U.S., the most impacted country.
https://nypost.com/2020/04/08/facebook-building-coronavirus-heat-map-by-asking-users-about-symptoms/